TLK-199 (Telik).

Abstract	Telik Inc is developing TLK-199, an intravenous inhibitor of glutathione S-transferase P1-1, for the potential prevention of myelosuppression in blood diseases, namely myelodysplastic syndrome.
Authors	David Hamilton, Gerald Batist
Journal	IDrugs : the investigational drugs journal (IDrugs) Vol. 8 Issue 8 Pg. 662-9 (Aug 2005) ISSN: 1369-7056 [Print] England
PMID	16044376 (Publication Type: Journal Article)
Chemical References	Enzyme Inhibitors Isoenzymes gamma-Glu-S-BzCys-PhGly diethyl ester GSTP1 protein, human Glutathione S-Transferase pi Glutathione Transferase Glutathione
Topics	Animals Bone Marrow Diseases (drug therapy, pathology) Enzyme Inhibitors (chemical synthesis, pharmacology, therapeutic use) Glutathione (analogs & derivatives, chemical synthesis, pharmacology, therapeutic use) Glutathione S-Transferase pi Glutathione Transferase (biosynthesis) Humans Isoenzymes (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!